Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

NCT05265247 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Diseases

Interventions

DRUG: Esomeprazole 20 mg Delayed-Release Capsules
DRUG: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR)

Sponsor

HALEON